The Specialist Pharmacy Service is asking CCGs to prepare for the entry to market this October of adalimumab biosimilars. Regular briefings will be issued by regional medicines optimisation committees. The briefings will also be of interest to medical directors, directors of nursing, chief pharmacists and others in trusts. An adalimumab biosimilar toolkit for commissioners and providers issued recently should help local hospital and pharmacy teams to put plans in place.
Musculoskeletal conditions are the single biggest cause of disability in the UK, accounting for 30% of GP consultations in England. A new framework published by NHS England and others is designed to help manage MSK problems appropriately at the first point of contact, and help to relieve pressures on primary and secondary care. The framework should be of interest to commissioners, employers, regulators and practitioners.
Social prescribing initiatives throughout the country will share £4.5m to extend existing schemes or start new ones. The fund is expected to benefit 23 projects in England. Social prescribing aims to improve patients’ quality of life, health and wellbeing by recognising that health is affected by a range of social, economic and environmental factors. It has also been shown to reduce demand on NHS services.
The Care Quality Commission has updated mythbusters and tips for general practice and dentistry. They are designed to help providers with the CQC inspection process and share agreed guidance and best practice.
If someone needs a wheelchair for a “short-term” ailment (officially, anything lasting less than six months), hospitals are not obliged to help. There is no clearly defined duty for statutory provision of wheelchair loans for short term use in any country in the UK. The British Red Cross is the biggest national provider of short term wheelchair loans and in 2017 loaned out 60,000 wheelchairs. Despite loaning tens of thousands of wheelchairs every year, they are concerned there is an unmet need for short-term wheelchair loans that persists across the UK. This report identifies the need for short-term loans of mobility aids, particularly wheelchairs, and the effect of lack of provision.